Today's quick video takes a closer look at Allergan (AGN) stock ahead of its coming earnings report. This pharma giant has been under pressure thanks to broad sector woes, as the industry is suffering under the weight of a bottom 40% industry rank.
However, AGN has seen decent earnings estimates heading into the report, and the company currently has a positive Earnings ESP too. Combine this with a Zacks Rank #3 (hold), and we have a pretty good chance for a beat when the company reports. This may be especially true when we consider the company's solid track record in earnings season, which includes modest beats in each of the past four quarters.
However, AGN does have some weakness in its build, including a 'D' grade for its fundamentals, as well as sliding estimates for the current year and next year time frames. This could be a case where the outlook weighs on the price, even if AGN is able to muster another beat this quarter.
ALLERGAN PLC Price, Consensus and EPS Surprise
Allergan reports on November 2 nd before the bell, and we are looking for earnings of $3.57/share. Make sure to watch the video for a quick guide to AGN heading into the report, but if you want to learn more about trading in earnings season, check out Zacks Live Trader .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.